Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


OGOG offers 25% premium in NZOG buyout

By Margreet Dietz

July 10 (BusinessDesk) - OG Oil & Gas has offered a 25 percent premium to buy out minority holders in New Zealand Oil and Gas.

Singapore-based OGOG, the oil and gas arm of Ofer Global and 70 percent-owner of NZOG, is offering 62 cents for the shares of the Wellington-based explorer it doesn't already own.

The NZOG board is recommending the offer, subject to confirmation the 62-cent offer prices is within or above the independent valuation yet to be determined by Northington Partners. NZOG shares closed at 49.5 cents on Tuesday, having dropped more than 16 percent in the past year.

The directors noted the changed operating environment for oil and gas investment in New Zealand since the government's April 2018 decision to stop awarding new offshore acreage, the challenges the company had faced raising equity as a result, and the "significant" decline in its share price since then.

"The independent directors believe recent policy changes have had a dramatic impact on the perception of New Zealand as an appealing place to invest in the oil and gas industry."

NZOG has a 4 percent stake in the Kupe gas field and a 5 percent interest in the Maari oil field through its Cue Energy subsidiary. It also has major stakes in the Clipper and Toroa exploration permits off the South Island and a 15 percent direct interest in the Ironbark project off north-western Australia. Drilling of the prospect by the BP-led venture is scheduled for late 2020. Cue also has a 21.5 percent stake in that venture.

NZOG said its board has formed a committee of the independent directors, Rosalind Archer and Rod Ritchie to consider OGOG’s proposal, to be effected through a scheme of arrangement.

NZOG shareholders will vote on the transaction at a special meeting expected in September 2019, the company said.

OGOG bought into NZOG in 2017, paying 78 cents a share for most of its holding.

“The attractive premium offered by OGOG comes despite an uncertain future for oil and gas investment in New Zealand,” NZOG's independent directors said. “Departures by major international players continue, with recent decisions by international companies to surrender exploration acreage being the latest examples.”

“Nevertheless, OGOG is willing to increase its investment in New Zealand Oil & Gas and in doing so will allow other shareholders to realise significant value given the current market conditions, policy environment and share trading history,” they noted.



© Scoop Media

Business Headlines | Sci-Tech Headlines


Marine And Freshwater Reports: EDS Calls For Urgent Action On Marine Management

“There are some big issues to address. These include many marine species and habitats that are in serious trouble. Of the sample investigated, the report finds that 22% of marine mammals, 90% of seabirds and 80% of shorebirds are threatened with or actually at risk of extinction..." More>>


$7.5 Billion Surplus: Government Accounts "Show Strong Economy"

“The surplus and low levels of debt show the economy is in good shape. This allows the Government to spend more on infrastructure and make record investments in health and education,” Grant Robertson says. More>>


New OIO Application Trumps Judicial Review: OceanaGold Cleared To Buy Land For Waihi Tailings Expansion

In a surprise turnaround, the government has given OceanaGold a greenlight to buy land to expand its Waihi mine after the application was previously turned down by Land Information Minister Eugenie Sage. More>>


Christchurch Rebuild: Fletcher Sued For $7.5m Over Justice Precinct

Fletcher Building is being sued for $7.5 million by utilities contractor Electrix, one of the subcontractors on the Christchurch Justice and Emergency Services Precinct. More>>

Three New Drugs: PHARMAC Signs Bundle Deal For More Cancer Medicines

420 New Zealanders with lung cancer, breast cancer, multiple sclerosis and respiratory disease will benefit each year from a bundle deal PHARMAC has finalised with a medicine supplier. More>>